Mirae Asset Global Etfs Holdings Ltd. Moderna, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.9 Billion
- Q4 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Moderna, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 103,018 shares of MRNA stock, worth $3.46 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
103,018
Previous 295,321
65.12%
Holding current value
$3.46 Million
Previous $19.7 Million
78.3%
% of portfolio
0.01%
Previous 0.05%
Shares
3 transactions
Others Institutions Holding MRNA
# of Institutions
923Shares Held
255MCall Options Held
19MPut Options Held
24.3M-
Vanguard Group Inc Valley Forge, PA40.3MShares$1.35 Billion0.03% of portfolio
-
Baillie Gifford & CO38.9MShares$1.31 Billion1.28% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$858 Million0.07% of portfolio
-
State Street Corp Boston, MA17.6MShares$590 Million0.03% of portfolio
-
Theleme Partners LLP London, X07.31MShares$245 Million20.37% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $13.1B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...